Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes - 12/04/19
Abbreviations used : CI, GI, HS, OR
Funding sources: None. |
|
Disclosure: Dr Pascual has been an advisory board member for Abbvie. Dr Romaní has given lectures or been an advisory board member for Abbvie, Almirall, Novartis, Leopharma. Dr Vilarrasa has received consultancy/speakers honoraria and/or participated in clinical trials sponsored by AbbVie, Almirall, Boheringer, Celgene, Janssen, Leo Pharma, Eli Lilly and Company, MSD, Novartis and Pfizer. Dr Azaña has received consultancy/speakers honoraria from AbbVie. Dr González-López has given lectures for Abbvie. Dr Cañueto has given lectures for Abbvie. Dr Schneller-Pavelescu, Dr Vergara-de Caso, Dr Martorell, Dr Lázaro, Dr Díaz-Ley, Dr Vázquez-Osorio, Dr Segura Palacios, Dr Molina-Leyva, Dr Leiva-Salinas, Dr Navarro-Triviño, and Dr Sánchez-Payá have no conflicts of interest to disclose. |
Vol 80 - N° 5
P. 1455-1457 - mai 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?